Evidence map›Paper›PMID 40966495›Full record

ArticleNucleic acids research2025

UVA-induced DNA damage and mutations in human melanocytes: relevance for melanoma mutations.

Seung-Gi Jin, Jennifer Johnson, Paul Y Kim, Gerd P Pfeifer

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seung-Gi JinDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, United States.
Jennifer JohnsonDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, United States.
Paul Y KimDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, United States.
Gerd P PfeiferDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, United States.ORCID 0000-0002-5080-9604

Funding

Mechanisms of cancer mutationsR01CA276031 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI Gerd P Pfeifer · 2023 to 2026
$1.9M
NCI NIH HHS R01 CA276031NIH HHS CA276031Peter C. and Emajean Cook foundationVan Andel Institute
6 · The paper itself

Abstract

UVB radiation (280-320 nm) from sunlight induces skin cancer through DNA damage-induced mutations. Melanomas carry mutational signatures associated with UVB-induced cyclobutane pyrimidine dimers (CPDs). However, there are several other melanoma signatures of unknown origin. To test if these signatures are linked to UVA, we exposed human melanocytes to UVA (340-400 nm) and to UVB for comparison. We mapped DNA damage in the form of CPDs or 8-oxoguanines (8-oxoG) genome-wide at base resolution. We then determined mutational patterns in single melanocyte cell clones by whole genome sequencing. Different from UVB, UVA induces CPDs more selectively at TT sequences resembling melanoma signature SBS7d. We did not observe rising CPD levels after cessation of radiation (dark CPDs). The UVA-induced CPDs were not mutagenic in the mutation analysis. 8-oxoG was present in melanocytes but did not substantially increase after UVA. G/C to T/A mutations were prominent in melanocyte single-cell clones with no major shift after UVA radiation. These mutations matched SBS18, a signature present in melanomas. Although UVA damages DNA, it has a surprisingly limited mutagenic effect on human melanocytes. However, the oxidative base lesions in melanocytes and their associated mutations may be linked to a subset of melanoma mutations.

Indexed as

DNA DamageMelanocytesMelanomaMutationUltraviolet RaysGuanineHumansPyrimidine DimersSkin Neoplasms8-hydroxyguanineGuaninePyrimidine Dimers

Identifiers

PMID40966495
PMCPMC12445662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.